Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00848874
Other study ID # 2R41MH075162
Secondary ID NIHM_2R41MH75162
Status Completed
Phase N/A
First received
Last updated
Start date September 2008
Est. completion date March 2010

Study information

Verified date October 2018
Source SymTrend Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Abstract: In Phase I, we designed and tested a Portable Visual Guidance System (PVGS), which combines a PDA - for user guidance - and an Internet website - for linking the user to an educational support team. Use of the PVGS 1) significantly improved the in vivo social pragmatics of students diagnosed with Aspergers Syndrome/Higher Functioning Autism (AS/HFA); 2) revealed additional ways of improving social pragmatics; and 3) improved activity management in scheduling and vocational tasks.

In Phase II, we will focus on social pragmatics and two closely related skills: feelings management and assignment management. We aim to:

1. Replicate Phase I success in the most educational setting for AS/HFA high school aged students: mainstream school inclusion classes.

2. Replicate Phase I findings more efficiently, with a less highly trained, on-site coaching staff and with more distant (non-site) expert supervision of that staff.

3. Contrast the outcomes of the curriculum with a diagnosis-matched wait-list control group.

4. Develop and implement software that will enable on-site staff to create and modify individualized guidance and monitoring screens as needs arise.

5. Design a commercially attractive package of software, video training, video-conferenced support, and manuals.

6. Complete the translation of the SymTrend website and all the above tools into Spanish.

Significance: Successful completion of Phase II will:

1. Provide a very effective and comprehensive system for teaching social pragmatics and related management skills to AS/HFA persons in an inclusion context.

2. Provide a means of evaluating IEP effectiveness, thereby enabling a better use of special education funds and a reduction of litigation over IEP plan appropriateness and utility.

3. Provide substantial support for our theoretical rationale for curriculum building in Special Education - a rationale that can guide the formulation of IEPs.

4. Provide a theoretical rationale, an intervention framework, and intervention support technology that can be extended to cognitive behavioral treatment of other neuropsychiatric disorders and can be adapted for other forms of healthcare guidance.

5. Provide an investigative system, as well as an intervention system, for tracking behavioral change in studies of frontal lobe and limbic neuroplasticity in neuropsychiatric disorders.


Recruitment information / eligibility

Status Completed
Enrollment 47
Est. completion date March 2010
Est. primary completion date March 2010
Accepts healthy volunteers No
Gender All
Age group 11 Years to 21 Years
Eligibility Inclusion Criteria:

- Ages 11-21

- Diagnosis of AS/HFA

- A student at participating high school and middle schools (Newton, MA; Brockton, MA; Veritas Christian Academy, Fletcher, NC; Durham, NC.

Exclusion Criteria:

- Participating in another study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
PVGS
Student use of SymTrend PVGS daily then tapering off for 14 weeks in conjunction to ratings by a coach.

Locations

Country Name City State
United States SymTrend, Inc. Belmont Massachusetts

Sponsors (3)

Lead Sponsor Collaborator
Minna Levine, PhD SymTrend Inc., University of North Carolina, Chapel Hill

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Students who use the PVGS will demonstrate improved classroom social pragmatics and executive functioning. Completion of intervention and three months hence
See also
  Status Clinical Trial Phase
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Recruiting NCT06187090 - The Supplementation Therapy in Autism and Response to Treatment Study N/A
Recruiting NCT05958680 - ASDactive: An Integrated Theory-based Intervention to Promote Habitual Physical Activity N/A
Recruiting NCT06227780 - Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders N/A
Completed NCT01187784 - Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and Anxiety Phase 1
Completed NCT00453180 - A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders Phase 2
Completed NCT00725556 - The Development of Autistic Children Based on Mothers´Response in Autism Behavior Checklist Phase 1/Phase 2
Completed NCT02800681 - Psychopathological Differences Between Asperger Syndrome and Schizotypal Disorder in an Adult Sample
Completed NCT00464477 - Advanced Grandparental Age as a Risk Factor for Autism N/A
Active, not recruiting NCT03170453 - Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder N/A
Recruiting NCT00505830 - Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome: AQ, EQ and SQ N/A
Suspended NCT04532424 - Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD N/A
Withdrawn NCT00693953 - Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism N/A
Completed NCT00619190 - Study of Aripiprazole to Treat Children and Adolescents With Autism Phase 2
Completed NCT00280670 - CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS Phase 2
Not yet recruiting NCT05509231 - Effects of a Multimodal Exercise Program for Children With ASD N/A
Completed NCT01337700 - Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism Phase 4
Completed NCT04788537 - Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders N/A
Completed NCT02250339 - A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric Disorders
Completed NCT01731119 - Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents Phase 2